President Biden Completes Fourth Dose of PAXLOVID Amid COVID-19 Recovery

US President Joe Biden has completed his fourth dose of PAXLOVID as part of his COVID-19 treatment. Despite ongoing mild symptoms, Biden's vital signs remain normal, according to his physician. He continues to manage presidential duties while in self-isolation in Delaware after testing positive on July 17.

US President Joe Biden, who has been under self-isolation at his Delaware residence after testing positive for COVID-19 early this week, has completed his fourth dose of PAXLOVID on Friday morning, according to his physician.

“President Biden completed his fourth dose of PAXLOVID this morning. His non-productive cough and hoarseness continue to be his primary symptoms, but they have improved meaningfully from yesterday,” White House physician Dr. Kevin C O'Connor stated in a memorandum to Press Secretary Karine Jean-Pierre.

The President's vitals, including pulse, blood pressure, and respiratory rate, remain normal. Oxygen saturation is excellent, and lungs are clear. PCR testing has confirmed the presence of SARS-CoV-2, with variant identification still pending. Bloodwork, including CBC and a Comprehensive Metabolic Panel, also came back normal, showing no signs of bacterial infection or any organ dysfunction.

Biden tested positive for COVID-19 on July 17 and has been working remotely from Delaware. He continues to handle all presidential responsibilities while undergoing treatment.